Hyderabad, 1t8th August, 2025: Zeus Hygia Lifesciences, a leading innovator in nutraceutical solutions, today announced the launch of Metaberine®, the world’s first green process enriched berberine developed using proprietary BioSOLVE Technology. Designed to overcome the limitations of conventional berberine extracts, Metaberine® delivers enhanced solubility, superior bioavailability, and a quicker onset of action all at a significantly lower dose.

The increasing prevalence of sedentary lifestyles and unhealthy dietary habits is contributing to a surge in metabolic disorders, with diabetes now affecting over 800 million adults worldwide. In recent years, GLP-1 receptor agonists have gained popularity for their dual benefits improving glycemic control and aiding in weight management. This dual efficacy addresses the interconnected challenges of diabetes and obesity, making GLP-1 therapies a vital option. However, high costs and limited accessibility of GLP-1 treatments highlight the urgent need for more affordable, effective alternatives. Emerging oral formulations aim to enhance convenience and affordability, and Metaberine® promising faster results at lower doses can help meet this critical need.

Berberine: Benefits and Limitations
Berberine is a naturally occurring alkaloid found in Berberine roots (Indian Barberry) and other plants. It is well-recognized for supporting metabolic health, cardiovascular function, and healthy lipid and glucose metabolism.

Despite its proven benefits, conventional berberine extracts face significant limitations: